Obesity surgery has been found to be the sole long-standing effectual method of weight reduction for people with morbid obesity. Obesity surgery classically appears to work superior as compared to diets, exercising or medications, however similar to all surgeries, there are associated risks, principally amongst these being the operative exposure of the abdominal area and the resultant scars.
However, there are least-invasive means, inclusive of a novel method created by a physician from a N. Carolina medical device firm, Southern Californian.
Doctor Brian Quebbemann, surgery head, The N.E.W. Program weight loss center, Newport Beach in collaboration with TransEnterix have developed the Spider operative device that helps a surgeon in performing bariatric surgery eliminating the need for the characteristic operative slit. The device makes its entry via tiny slit made in the navel (belly-button) and curbing the abdominal capacity by nearly eighty percent.
Having garnered the FDA approval in 2009, the Spider contains several appliance conduits which allow the surgeons in inserting pliable instruments for expanding the abdominal region (similar to a sunshade), mini cameras for viewing the operative surroundings, and operative devices for trimming the abdomen and suturing. Removal of the Spider is then done via the analogous aperture.
Presently on the sphere is a multi-centred trial to garner the FDA nod is the TOGA System, a minimally invasive bariatric surgery method which is basically an endoscopic method (via the oral route). Pair of bendable tools is introduced via the oral way inside the abdominal region for stapling together segments of the stomach and hence lower its total capacity of foods.
No sooner has the TOGA System been positioned properly, suctioning mechanism is employed for gathering all tissues from all abdominal sides together inside the tool. Fastening together of the gathered tissues are then done employing titanium staple types. The method would lead to the creation of a mini tummy pouch with the shape like a constricted sleeve at the base of the tummy. No sooner has the stomach stapling done, the method has been completed, the tool is taken out from the body interiors.
The general outcome of this weight loss procedure is to assist a patient in feeling fuller quicker and thus eating lesser food serves. As the TOGA system does not employ an implant like gastric bands, hence it does not carry the linked implant issues.
The TOGA System is presently under trial stages in the U.S. which is intended on evaluating the safety quotient and efficacy of the method for treating morbid obesity.